# Optimal levetiracetam dosage regimen for preventing seizures related to immune effector cell-associated neurotoxicity syndrome

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41409-026-03038-1) · 2026-11-14 · Life
Page: https://themorning.science/story/optimal-levetiracetam-dosage-regimen-for-preventing-seizures-related-to-immune-e-bd008f3c1104e252
Kind: research · Impact: medium

## In brief

- A study published on nature.com examines the optimal levetiracetam dosage regimen for preventing seizures linked to immune effector cell-associated neurotoxicity syndrome (ICANS) after CAR-T therapy.
- The source provided contains only the title and no summary, so specific findings and dosing results are not available here.

## Why it matters

Seizures are a neurotoxic complication of CAR-T therapy, so evidence on the dosing regimen used to prevent them matters for clinicians managing these patients.

## Timeline

- 2026-11-14: Study appeared in nature.com subject feed

## Coverage

- [Optimal levetiracetam dosage regimen for preventing seizures related to immune effector cell-associated neurotoxicity syndrome](https://www.nature.com/articles/s41409-026-03038-1) — Biological sciences : nature.com subject feeds, 2026-11-14

Tags: car-t, levetiracetam, neurotoxicity, seizures, clinical-dosing

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science